Old Web
The use of novel PP2A activators in combination with PARP inhibitor for the treatment of high-grade serous ovarian cancer
2017
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI